New FFG Grant

We are delighted to share that our company has been selected to receive a grant from the Austrian Lifesciences Programme, a prestigious initiative administered by the Austrian Research Promotion Agency. This grant is a testament to the innovative work we are doing in the field of life sciences and will help us to continue pushing the boundaries of scientific research and development. With the support of the Austrian Life Sciences Programme, we can accelerate our efforts on our ground-breaking ideas.

Our Presentation at EuroPCR 2023

We are excited to announce that our company will not only participate in EuroPCR 2023, but we will also be giving a presentation at the conference! This is a fantastic opportunity for us to showcase our latest research and innovation.
 
EuroPCR is one of the largest and most prestigious conferences in the field of cardiology, and we are honored to be a part of it.
 
We invite you to join us at EuroPCR 2023 to learn more about our innovative implant and hear our presentation.

Our Presentation at TCT 2022

Here are a few Photos from the successful presentation of AVVie´s Mitral Butterfly by Mathew R. Williams from NYU Langone Health at TCT in Boston.
We hope to see you all again next year!

Lies weiter

Presentation at Transcatheter Cardiovascular Therapeutics (TCT) Conference in Boston

We are excited to announce that AVVie will be attending TCT 2022 Boston.

The Transcatheter Cardiovascular Therapeutics (TCT) conference is the Cardiovascular Research Foundation’s (CRF) annual scientific symposium. The world’s foremost educational forum specializing in interventional cardiovascular medicine will be held on September 16-19, 2022, at Boston Convention and Exhibition Center.

Dr. Mathew R. Williams will present our technology and latest achievements on September 18th in TCT Innovation: Transcatheter Mitral Valve Technologies session.

AVVie Awarded EU Seal of Excellence

AVVie was recently given the Seal of Excellence by the European Commission, a prestigious recognition for superior, innovative concepts deserving financial support. With this award, the European Commission affirms AVVie as a highly innovative company that can successfully compete globally in fast-growing areas.

The Seal of Excellence is a high-quality certificate given to projects submitted to the Horizon Program that have met all the strict selection and award requirements but were unable to get funding because of budgetary restrictions. The „Seal“ proves that the AVVie has commercial value and justifies support from different sources, whether public, private, national, regional, European, or global.

For more information about the Seal of Excellence, visit www.ec.europe.eu